elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Pricing
Log in
Sign up
Home
/
Subjects
/
Mesothelioma
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Mesothelioma
RIS
0.000
(Research Intensity Score)
Papers
53
Top papers
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
2023 · 253 citations
Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial
2021 · 137 citations
ONCOS-102 plus pemetrexed and platinum chemotherapy in malignant pleural mesothelioma: a randomized phase 2 study investigating clinical outcomes and the tumor microenvironment
2023 · 38 citations
A Comparative Study of 157 Gd and 10 B Effect in a Carborane-Based Theranostic Agent for Membrane-Targeted Carbonic Anhydrase IX Inhibition and MRI-Guided Neutron Capture Therapy in Mesothelioma Treatment
2025 · 7 citations
A combination of PD-1 and TIGIT immune checkpoint inhibitors elicits a strong anti-tumour response in mesothelioma
2025 · 11 citations
First-in-human study of a thorium-227-labeled mesothelin-targeting antibody-chelator conjugate (MSLN-TTC), in patients with malignant mesothelioma and other solid tumors
2025 · 4 citations
Pseudo-senescence induced by palbociclib does not sensitise pleural mesothelioma cells to combinations with senolytics
2026 · 2 citations
KEYNOTE ‐ A17 : First‐Line Pembrolizumab Plus Cisplatin–Pemetrexed in Japanese Participants With Advanced Pleural Mesothelioma
2025 · 6 citations
EVALUATION OF THE EFFICACY AND SAFETY OF HYPERTHERMIC INTRATHORACIC CHEMOTHERAPY IN MALIGNANT PLEURAL DISEASES
2026
Newest papers
Pseudo-senescence induced by palbociclib does not sensitise pleural mesothelioma cells to combinations with senolytics
2026 · 2 citations
EVALUATION OF THE EFFICACY AND SAFETY OF HYPERTHERMIC INTRATHORACIC CHEMOTHERAPY IN MALIGNANT PLEURAL DISEASES
2026
The provision of psychological care for patients with mesothelioma and their caregivers: an Italian survey
2026
Unexpected insight: Rubidium-82 PET/CT myocardial perfusion imaging uncovers malignant pleural mesothelioma
2026
A Comparative Study of 157 Gd and 10 B Effect in a Carborane-Based Theranostic Agent for Membrane-Targeted Carbonic Anhydrase IX Inhibition and MRI-Guided Neutron Capture Therapy in Mesothelioma Treatment
2025 · 7 citations
A combination of PD-1 and TIGIT immune checkpoint inhibitors elicits a strong anti-tumour response in mesothelioma
2025 · 11 citations
First-in-human study of a thorium-227-labeled mesothelin-targeting antibody-chelator conjugate (MSLN-TTC), in patients with malignant mesothelioma and other solid tumors
2025 · 4 citations
KEYNOTE ‐ A17 : First‐Line Pembrolizumab Plus Cisplatin–Pemetrexed in Japanese Participants With Advanced Pleural Mesothelioma
2025 · 6 citations
miRNA-503 inhibition exerts anticancer effects and reduces tumor growth in mesothelioma
2025 · 7 citations
Browse all papers →
Mesothelioma's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
Mesothelioma's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link